Announcements Trials

Browse Landscape

Phase

Status

Completed 16 Unknown 4 Recruiting 2 Not yet recruiting 2 Terminated 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 35 Breast Neoplasms 30 Prostatic Neoplasms 21 Colorectal Neoplasms 21 Leukemia, Myeloid, Acute 19 Pancreatic Neoplasms 17 Melanoma 17 Glioblastoma 16 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 15 Lung Neoplasms 13 Brain Neoplasms 13 Glioma 12 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 11 Ovarian Neoplasms 9 Multiple Myeloma 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Lymphoma 8 Carcinoma, Renal Cell 8 Rectal Neoplasms 6 Leukemia 6 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Recurrence 5

Interventions

Interpersonal Psychotherapy 1 Escitalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Depressive Disorder, Major × Clear all

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡